Pfizer Inc. (PFE) financial statements and ratios from SEC XBRL: revenue $62.58B (TTM), net margin 12.4%, revenue growth 2.6% YoY, P/E 36.5. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $62.58B |
| Net Margin | 12.4% |
| Revenue Growth (YoY) | 2.6% |
| EPS Growth (YoY) | -107.8% |
| FCF Growth (YoY) | -125.2% |
| P/E Ratio | 36.5 |
| EV / EBITDA | 20.4 |
| Price / Book | 1.85 |
| Price / Sales | 2.49 |
| FCF Yield | 6.9% |
| DCF Value (model) | $22.49 |
| DCF Upside vs Price | -19.0% |
| Altman Z-Score | 2.01 (grey) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
PFE overview · PFE earnings · PFE KPIs · PFE investor relations · PFE ownership · PFE peers · PFE filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.